Drug Type Prophylactic vaccine |
Synonyms Influenza A virus vaccine H5N1(Novartis Pharma AG), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23), prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (28 Nov 2010), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Influenza A virus infection | EU | 09 Oct 2023 | |
Influenza A virus infection | IS | 09 Oct 2023 | |
Influenza A virus infection | LI | 09 Oct 2023 | |
Influenza A virus infection | NO | 09 Oct 2023 | |
Influenza in Birds | EU | 28 Nov 2010 | |
Influenza in Birds | IS | 28 Nov 2010 | |
Influenza in Birds | LI | 28 Nov 2010 | |
Influenza in Birds | NO | 28 Nov 2010 |
Phase 2 | 405 | (Concomitant Alone) | zvqeowuvgc(onevuvmcbi) = gferqgbocq dehtvozxbl (votojxwzzh, urwjbozzit - kwmndbxfhy) View more | - | 28 Feb 2013 | ||
(Mixed) | zvqeowuvgc(onevuvmcbi) = tkyuusbstj dehtvozxbl (votojxwzzh, tnczknjrmd - jrvbuxrfcb) View more |